Not finding it? Sign in to also search OpenAlex live.
-
Beyond the Amount: The Selectivity of Proteinuria and Risk of Graft Failure in Kidney Transplant Recipients2026 American Journal of Nephrology article Medicine Renal Transplantation Outcomes and Treatments Open access
Firas Farisi Alkaff, Wendy Dam, Jenny E. Kootstra‐Ros, Eva Corpeleijn, Mohamed R. Daha, Martin H. de Borst, +3 more
0citations -
PROTECT Subgroup Analysis: Clinical Benefits of Sparsentan (SPAR) vs. Irbesartan (IRB) in Patients with IgAN Who Have Proteinuria above and below 1 g/g2024 Journal of the American Society of Nephrology article Medicine Renal Diseases and Glomerulopathies
Laura Ann Kooienga, Hernán Trimarchi, Jürgen Floege, Priscila Preciado, Jai Radhakrishnan
0citations -
The risk of nephrotic range proteinuria and kidney failure in primary laminopathies is genotype specific2026 JCI Insight article Biochemistry, Genetics and Molecular Biology Nuclear Structure and Function Open access
Sebastian Sewerin, Charlotte Aurnhammer, Mohamed Hamed, Gwladys Revêchon, Ria Anne-Rose Schönauer, Christin Findeisen, +26 more
0citations -
Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes: the CARMELINA randomized controlled trial
Christoph Wanner, Mark Emmanuel Cooper, Odd Erik Johansen, Robert Daniel Toto, Julio Rosenstock, Darren K. McGuire, +10 more
18citations -
Origin 3: Pivotal phase 3 study evaluating effect of atacicept vs placebo on proteinuria and renal function preservation in iga nephropathy2024 RWTH Publications (RWTH Aachen) article Medicine Renal Diseases and Glomerulopathies Open access
Jonathan Barratt, Bart Maes, Rubeen Israni, Xuelian Wei, Jürgen Flöge, Vivekanand Jha, +7 more
0citations -
2019 Update of the Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA–EDTA) recommendations for the management of lupus nephritis2020 Annals of the Rheumatic Diseases article Medicine Systemic Lupus Erythematosus Research Open access cited by 7 patents
Antonis Fanouriakis, Myrto Kostopoulou, Kim Cheema, Hans‐Joachim Anders, Martin Aringer, Ingeborg M. Bajema, +21 more
833citations -
Sodium-glucose cotransporter 2 inhibition in primary and secondary glomerulonephritis2023 Nephrology Dialysis Transplantation article Medicine Renal Diseases and Glomerulopathies Open access
Fernando Caravaca‐Fontán, Kate Stevens, Maite Padrón, Ana Huerta, Marco Montomoli, Juan Villa, +45 more
47citations -
#2652 ANTIPROTEINURIC EFFECT OF SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS IN GLOMERULAR AND SYSTEMIC DISEASES: A REAL-WORLD CLINICAL STUDY2023 Nephrology Dialysis Transplantation article Medicine Renal Diseases and Glomerulopathies Open access
Fernando Caravaca‐Fontán, Kate Stevens, Andreas Kronbichler, Hans‐Joachim Anders, Jürgen Floege, Gema Maria Fernandez Juarez, +1 more
0citations -
#3242 Long-term outcomes in IgA nephropathy: findings from the ERKNet patient registry (ERKReg)2025 Nephrology Dialysis Transplantation article Medicine Renal Diseases and Glomerulopathies Open access
Eyal Rahmani, Licia Peruzzi, Jürgen Floege, Dario Roccatello, Enrique Morales Ruiz, Olivia Boyer, +6 more
0citations -
Apical tubular complement activation and the loss of kidney function in proteinuric kidney diseases2024 Clinical Kidney Journal article Immunology and Microbiology Complement system in diseases Open access
Firas Farisi Alkaff, Rosa G. M. Lammerts, Mohamed R. Daha, Stefan P. Berger, Jacob van den Born
12citations -
Inhibition of the glucocorticoid receptor attenuates proteinuric kidney diseases in multiple species2023 Nephrology Dialysis Transplantation article Medicine Renal Diseases and Glomerulopathies Open access
Eleni Stamellou, Shipra Agrawal, Florian Siegerist, Marc Buse, Christoph Kuppe, Tim Lange, +10 more
5citations -
Role of Systemic Glucocorticoids in Reducing IgA and Galactose-Deficient IgA1 Levels in IgA Nephropathy2025 Clinical Journal of the American Society of Nephrology article Medicine Renal Diseases and Glomerulopathies Open access
Jincan Zan, Jingyi Li, Muh Geot Wong, Dana Kim, Sufang Shi, Helen Monaghan, +3 more
7citations -
Alternative pathway–mediated tubular complement activation in human proteinuric kidney diseases: a proof-of-concept study2025 Clinical Kidney Journal article Immunology and Microbiology Complement system in diseases Open access
Firas Farisi Alkaff, Rosa G. M. Lammerts, Gesa Tiller, Marius Christianus van den Heuvel, Ingeborg M. Bajema, Mohamed R. Daha, +2 more
5citations -
#2651 Sustainability and depth of UPCR reduction in patients with primary IgAN treated with nefecon: a secondary analysis of the Phase 3 NefIgArd trial2025 Nephrology Dialysis Transplantation article Medicine Renal Diseases and Glomerulopathies Open access
Jonathan Barratt, Heather N. Reich, Jens Halkjaer Kristensen, Russell F Jones, Jürgen Floege, Vladimı́r Tesař, +4 more
0citations -
#3345 Nefecon provides kidney benefit irrespective of baseline eGFR in patients with IgAN: a subanalysis of the NefIgArd study2025 Nephrology Dialysis Transplantation article Medicine Renal Diseases and Glomerulopathies Open access
Jonathan Barratt, Richard A. Lafayette, Heather N. Reich, Jens Halkjaer Kristensen, Russell F Jones, Jürgen Floege, +4 more
0citations